YOLFTbeta
01

WooGene B&G Co. Ltd

018620 · KQ · Healthcare / Pharmaceuticals

2,765.00KRW-30.00 (-1.07%)

Price History

Full chart

Market Stats

Previous Close2,795.00
Open2,780.00
Day Range2,710.00 – 2,780.00
52-Week Range2,120.00 – 4,358.33
Volume1.38K
Market Cap18.64B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.89
50-Day Avg2,691.50
200-Day Avg2,913.50

About

WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Jae-Ku Kang
  • Employees93
  • Headquarters775, Gyeongin-ro, Seoul, South Korea, Korea
  • Websitehttps://www.woogenebng.com

Leadership

  • Mr. Jae-Ku KangCEO & Pres · b. 1943
  • Kyung-Duk YangSr. Managing Director · b. 1953

Financials

Income Statement

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue18.06B21.27B22.09B23.51B27.82B26.43B30.62B33.62B39.52B39.35B43.70B57.92B55.68B54.76B
Growth (%)-+17.79%+3.85%+6.43%+18.34%-4.98%+15.84%+9.79%+17.56%-0.45%+11.07%+32.53%-3.87%-1.65%
Cost of Revenue12.26B14.25B14.62B16.94B21.12B21.35B28.93B27.13B31.26B31.06B34.23B42.98B39.48B38.23B
Gross Profit5.79B7.02B7.47B6.56B6.70B5.08B1.69B6.49B8.26B8.29B9.47B14.94B16.20B16.53B
Gross Margin32.09%32.99%33.83%27.92%24.09%19.22%5.53%19.30%20.91%21.07%21.67%25.79%29.09%30.19%
Operating Expense4.83B5.31B6.62B6.61B6.58B8.50B7.35B16.25B7.60B10.82B7.99B14.46B24.20B16.21B
Operating Income966.61M1.71B852.82M-50.10M125.82M-3.41B-5.66B-9.76B663.65M-2.53B1.48B482.16M-8.01B319.17M
Operating Margin5.35%8.03%3.86%-0.21%0.45%-12.92%-18.48%-29.02%1.68%-6.44%3.38%0.83%-14.38%0.58%
EBITDA----------4.59B4.33B994.28M5.01B
EBITDA Margin----------10.51%7.48%1.79%9.15%
Net Income731.63M1.28B821.34M352.76M175.43M-4.19B-6.63B-12.79B-2.06B-2.26B849.57M-1.18B-5.22B-1.77B
Net Income Margin4.05%6.00%3.72%1.50%0.63%-15.85%-21.66%-38.03%-5.22%-5.74%1.94%-2.04%-9.38%-3.24%
R&D512.68M512.68M261.13M264.92M124.96M512.68M106.30M-105.32M305.23M270.35M907.01M1.18B1.27B
R&D as % of Total Revenue2.84%2.41%1.18%1.13%0.45%1.94%0.35%-0.27%0.78%0.62%1.57%2.12%2.31%
Interest Expense000000001.98B1.75B1.61B2.14B2.83B2.91B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.02%4.45%3.69%3.70%5.08%5.32%

Balance Sheet

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets25.81B26.18B29.06B42.24B58.15B60.64B60.05B85.13B77.56B76.51B91.52B121.58B112.87B109.03B
Total Liabilities8.06B7.62B8.39B20.34B36.01B37.60B33.54B57.87B47.72B45.36B56.20B49.25B85.08B45.09B
Total Equity17.74B18.56B20.67B21.90B22.14B23.04B26.51B27.27B29.85B31.14B35.32B33.52B27.79B30.80B
Cash554.02M622.40M547.67M3.13B5.66B339.69M1.91B5.40B9.06B11.03B19.70B13.59B16.81B13.63B
Total Debt---17.00B28.87B21.80B24.01B23.77B9.90B-----
Net Debt-------12.30B12.23B9.03B-14.50B14.12B16.82B

Cash Flow

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow773.08M2.08B1.48B-1.57B2.85B-1.54B-3.72B-1.85B2.47B4.09B2.57B2.76B6.78B3.87B
Investing Cash Flow-420.58K-906.25M-2.08B-9.24B-14.00B-8.52B-1.62B-13.24B-7.85B-1.25B-8.36B-14.43B-4.01B-
Financing Cash Flow-929.74M-1.08B948.34M13.54B14.49B4.72B6.49B18.26B9.48B-977.10M14.46B5.57B434.77M-
Capital Expenditure268.63M504.95M2.38B9.14B14.51B8.65B858.93M2.71B5.27B2.41B512.72M1.76B8.26B2.81B
Free Cash Flow--------1.16B-3.17B1.64B2.12B-574.90M-1.56B1.06B
Dividends Paid221.97M220.53M-191.38M300---------
FCF to OCF-------62.64%-128.46%40.08%82.58%-20.87%-23.00%27.38%

Earnings

Report DateDec 31, 2009Jun 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Aug 13, 2015Nov 17, 2015Feb 12, 2016May 16, 2016Aug 16, 2016Nov 14, 2016Feb 15, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Mar 12, 2018May 15, 2018Aug 10, 2018Nov 14, 2018Mar 11, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual79.0654.9187.8843.7358.73-35.41151.85102.2537.87170.2274.8633.5913.92-2.48138.91120.466.9626.1098.0973.7620.691.55-17.31-21.9121.49-7.1418.00-44.64-140.92-80.26-12.58-85.21-133.81-65.69-79.28-242.62-135.88-103.13-1636.95-15.42-186.34221.11-337.45-156.3274.83-5.51-241.2452.53-14.358.1376.22-44.2088.79-122.05-93.2927.38212.0432.84-1025.3349.06217.46-122.66-399.67-3.43165.44
Surprise-----------------------------------------------------------------
Timing--------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market------------------------------

Key Statistics & Ratios

Market Cap18.64B
Enterprise Value34.11B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.34
Price / Book0.60
Revenue (TTM)47.58B
Gross Profit (TTM)8.19B
EBITDA3.62B
Profit Margin-2.84%
Operating Margin2.83%
Return on Equity-1660.58%
Return on Assets1.10%
Shares Outstanding25.97M
Shares Float22.49M
Beta0.89
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20141×
54.10Dec 29, 2014
20111×
66.06Dec 28, 2011
20101×
66.06Dec 29, 2010
20091×
66.06Dec 29, 2009
20081×
66.06Dec 29, 2008

Stock Splits

  • Jun 12, 20266:5
  • May 21, 20261:5
  • Jan 3, 20192038:1775
  • Feb 6, 201811:10
  • Dec 22, 2017699:662
  • Dec 28, 201621:20
  • Dec 29, 201511:10
  • Oct 7, 20142:1
  • Dec 27, 2013832:751
  • Dec 27, 2012917:827